Tumor News and Research

RSS

New combination treatment offers significant benefits for people with recurring grade 3 astrocytoma

Huntsman Cancer Institute at the University of Utah (the U) participated in a clinical trial that found that a new combination treatment plan helped people with recurring grade 3 astrocytoma, an aggressive form of brain cancer, live longer.

8 Dec 2025

Lower dose of immunotherapy for malignant melanoma improves results

According to a new study, lower doses of approved immunotherapy for malignant melanoma can give better results against tumors, while reducing side effects.

8 Dec 2025

New atomic structure reveals how NBCn1 transporter protein aids breast cancer cell survival

UCLA scientists have characterized the structure and function of a key survival protein in breast cancer cells that helps explain how these tumors resist environmental stress and thrive in acidic, low-oxygen environments that would normally be toxic to healthy cells.

5 Dec 2025

AI model could help radiologists identify brain abnormalities in MRI scans

A new AI model could help radiologists identify brain abnormalities in MRI scans for all conditions including stroke, multiple sclerosis and brain tumors.

5 Dec 2025

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows quickly, spreads early and lacks the hormone receptors that make other breast cancers treatable with targeted therapies.

5 Dec 2025

New combination treatment helps people with recurring grade 3 astrocytoma, trial shows

5 Dec 2025

Study shines light on how P2X4 receptor can be inhibited

A study carried out by the University of Bonn and the University Hospital Bonn throws light on how an important receptor can be inhibited.

5 Dec 2025

Engineered herpes virus activates potent immune responses against glioblastoma

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells.

4 Dec 2025

Urine cfDNA patterns emerge as a promising tool for diagnosing bladder cancer

Researchers have discovered that analyzing specific patterns of cell-free DNA (cfDNA) fragmentation in a simple urine sample can effectively diagnose and stage bladder cancer, offering a much-needed alternative to invasive procedures like cystoscopies.

4 Dec 2025

Breakthrough in imaging speed moves portable stroke diagnosis closer to reality

When someone walks into an emergency room with symptoms of a stroke, every second matters. But today, diagnosing the type of stroke, the life-or-death distinction between a clot and a bleed, requires large, stationary machines like CT scanners that may not be available everywhere.

4 Dec 2025

Scientists uncover why SETX-deficient cancer cells rely on error-prone DNA repair

The DNA inside our cells is constantly being damaged, and one of the worst kinds of damage is a double-strand break-when both sides of the DNA helix are cut at once.

4 Dec 2025

Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapy

A study led by researchers at the Hospital del Mar Research Institute advances one of the most significant milestones in breast cancer treatment, making immunotherapy effective against the most common tumor type, estrogen receptor-positive or luminal breast cancer.

4 Dec 2025

Organ-on-a-chip system reveals how aging weakens vaccine-driven anti-cancer immunity

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing.

4 Dec 2025

New drug combination shows promise for overcoming resistance in ovarian cancer

Previous
1
...
52
53
54
55
56
57
58
...
1367
Next

Tumor News and Research

New combination treatment offers significant benefits for people with recurring grade 3 astrocytoma

Lower dose of immunotherapy for malignant melanoma improves results

New atomic structure reveals how NBCn1 transporter protein aids breast cancer cell survival

AI model could help radiologists identify brain abnormalities in MRI scans

Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer

New combination treatment helps people with recurring grade 3 astrocytoma, trial shows

Study shines light on how P2X4 receptor can be inhibited

Engineered herpes virus activates potent immune responses against glioblastoma

Urine cfDNA patterns emerge as a promising tool for diagnosing bladder cancer

Breakthrough in imaging speed moves portable stroke diagnosis closer to reality

Scientists uncover why SETX-deficient cancer cells rely on error-prone DNA repair

Study uncovers strategy to sensitize estrogen receptor–positive breast tumors to immunotherapy

Organ-on-a-chip system reveals how aging weakens vaccine-driven anti-cancer immunity

New drug combination shows promise for overcoming resistance in ovarian cancer

Common childhood virus linked to bladder cancer later in life

Injectable scaffold vaccine shows strong protection against implant-related MRSA

Sweat testing could transform drug monitoring and diabetes care

New analysis reveals fundamental flaws in widely used measures of biological aging

Sugar alcohol sorbitol may increase the risk of developing steatotic liver disease

New investment aims to accelerate treatments for low-grade brain tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News